Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study: Phase I/II study of a rheumatoid arthritis drug used in systemic sclerosis shows signs of efficacy and RNA technology is instrumental in the discovery

Health News Comments Off on Tofacitinib shows promise in scleroderma patients, researchers optimistic for next phase of study: Phase I/II study of a rheumatoid arthritis drug used in systemic sclerosis shows signs of efficacy and RNA technology is instrumental in the discovery